MXPA02011424A - Preparacion farmaceutica para el diagnostico de infeccion por helicobacter pylori. - Google Patents

Preparacion farmaceutica para el diagnostico de infeccion por helicobacter pylori.

Info

Publication number
MXPA02011424A
MXPA02011424A MXPA02011424A MXPA02011424A MXPA02011424A MX PA02011424 A MXPA02011424 A MX PA02011424A MX PA02011424 A MXPA02011424 A MX PA02011424A MX PA02011424 A MXPA02011424 A MX PA02011424A MX PA02011424 A MXPA02011424 A MX PA02011424A
Authority
MX
Mexico
Prior art keywords
preparations
infection
pylori
helicobacter pylori
weight
Prior art date
Application number
MXPA02011424A
Other languages
English (en)
Inventor
Atsunari Noda
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26592228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA02011424(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MXPA02011424A publication Critical patent/MXPA02011424A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Atmospheric Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere a preparaciones mediante las cuales la infeccion por H. pylori puede ser detectada rapidamente, mientras eliminan los efectos de bacterias que producen ureasa que existen en organos aparte del tracto gastrointestinal, es decir, cavidad oral, garganta, etc. sin temor alguno de la deteccion de falsos positivos; a saber, la presente invencion se refiere a preparaciones para detectar la infeccion por H. pylori mediante la prueba de expiracion de urea, en donde una composicion de nucleo que contiene por lo menos urea marcada con isotopo de carbono, un llenador y un lubricante a una relacion definida, es recubierta e su superficie con 0.1 a 10% en peso, por 100% en peso de la composicion de nucleo, de un recubrimiento.
MXPA02011424A 2000-05-19 2001-05-17 Preparacion farmaceutica para el diagnostico de infeccion por helicobacter pylori. MXPA02011424A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000148150 2000-05-19
JP2000259845 2000-08-29
PCT/JP2001/004122 WO2001087353A1 (en) 2000-05-19 2001-05-17 Preparations for diagnosing infection with helicobacter pylori

Publications (1)

Publication Number Publication Date
MXPA02011424A true MXPA02011424A (es) 2003-04-25

Family

ID=26592228

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011424A MXPA02011424A (es) 2000-05-19 2001-05-17 Preparacion farmaceutica para el diagnostico de infeccion por helicobacter pylori.

Country Status (13)

Country Link
EP (1) EP1283060B1 (es)
JP (1) JP4683812B2 (es)
KR (1) KR100774014B1 (es)
CN (1) CN1263516C (es)
AU (2) AU5676801A (es)
BR (1) BR0110954A (es)
CA (1) CA2408992C (es)
DE (1) DE60143196D1 (es)
HK (1) HK1063741A1 (es)
MX (1) MXPA02011424A (es)
PT (1) PT1283060E (es)
TW (1) TWI296530B (es)
WO (1) WO2001087353A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60122939T2 (de) 2000-12-21 2007-01-11 Nitromed, Inc., Bedford Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
US20080146956A1 (en) * 2006-12-17 2008-06-19 Campuzano German A Method based on a breath test for the detection of pathogen microorganisms
CN101231284B (zh) * 2007-01-23 2012-09-26 深圳市先亚生物科技有限公司 诊断幽门螺杆菌感染的尿素试剂盒
ITMI20121462A1 (it) * 2012-08-31 2014-03-01 Francesco Maria Bulletti Preparato a rilascio vaginale per la diagnosi della pervietà e della funzione utero tubarica femminile umana finalizzata alla fecondazione dei gameti
CN106620736A (zh) * 2016-11-09 2017-05-10 北京勃然制药有限公司 一种新型尿素[13c]检测药剂
KR102637908B1 (ko) 2018-12-28 2024-02-20 씨제이제일제당 (주) 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06157317A (ja) * 1992-11-19 1994-06-03 Nisshin Flour Milling Co Ltd 消化性潰瘍治療剤
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
JP2768559B2 (ja) * 1994-11-02 1998-06-25 ダイアバクト・エイ・ビー ヘリコバクテル・ピロリ（Ｈｅｌｉｃｏｂａｃｔｅｒ Ｐｙｌｏｒｉ）の検出のための診断用調剤
TW438608B (en) * 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
JP3963982B2 (ja) * 1995-08-02 2007-08-22 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
ES2145624T3 (es) * 1996-08-13 2000-07-01 Kyowa Hakko Kogyo Kk Comprimidos a base de urea marcada con isotopos.
WO1998033857A1 (en) * 1997-01-31 1998-08-06 Elisha Technologies Co. L.L.C. Corrosion protective coatings
MX9703918A (es) * 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.

Also Published As

Publication number Publication date
JPWO2001087353A1 (ja) 2004-04-30
WO2001087353A1 (en) 2001-11-22
EP1283060A4 (en) 2006-03-22
PT1283060E (pt) 2010-11-22
EP1283060A1 (en) 2003-02-12
CA2408992C (en) 2010-03-23
CN1489478A (zh) 2004-04-14
EP1283060B1 (en) 2010-10-06
CA2408992A1 (en) 2002-11-18
AU2001256768B2 (en) 2006-03-02
DE60143196D1 (de) 2010-11-18
CN1263516C (zh) 2006-07-12
JP4683812B2 (ja) 2011-05-18
KR20030001506A (ko) 2003-01-06
AU5676801A (en) 2001-11-26
TWI296530B (en) 2008-05-11
KR100774014B1 (ko) 2007-11-08
BR0110954A (pt) 2005-01-11
HK1063741A1 (en) 2005-01-14

Similar Documents

Publication Publication Date Title
Mohsenin Effect of vitamin C on NO2-induced airway hyperresponsiveness in normal subjects
Kellow et al. Sulfapyridine appearance in plasma after salicylazosulfapyridine: another simple measure of intestinal transit
Casellas et al. Hydrogen breath test with glucose in exocrine pancreatic insufficiency
CA2160916A1 (en) Test composition for the rapid detection of helicobacter pylori in gastric biopsy tissue
AU3861095A (en) Diagnostic preparation for detection of helicobacter pylori
BR9813519A (pt) Aparelho e método para inalação
MX9402938A (es) Composicion terapeutica que comprende nicotinamida-adenina-dinucleotido ynicotinamida-adenina-fosfato-dinucleotido, estable ingerible y absorbible.
CA2191858A1 (en) Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
EP1083427A3 (en) Method and apparatus for determining gas content
EP0190893A3 (en) Test kit and method for the determination of streptococcus mutans
MXPA02011424A (es) Preparacion farmaceutica para el diagnostico de infeccion por helicobacter pylori.
BR9815723A (pt) Conector para conectar uma fonte de ar a um respirador e conjunto de conector para conectar um tubo de respiração a um respirador
DK0699414T3 (da) Anlæg til sygdomsbehandling
CA2468858A1 (en) Breath test
Meineke et al. Evaluation of the 13CO2 kinetics in humans after oral application of sodium bicarbonate as a model for breath testing
DE69713588T2 (de) Diagnostische zusammensetzung
ES2211046T3 (es) Procedimiento y composicion para inhibir la produccion de oxido nitrico en la cavidad oral.
EP1532279A4 (en) METHOD, COMPOSITION AND ANTIGEN BINDING KIT OF NORWALK VIRUS
CA2366922A1 (en) Formulations for detecting asthma
CN204410818U (zh) 一种改进的尿素呼气试验药盒
Schlesinger et al. Pulmonary effects of repeated episodic exposures to nitric acid vapor alone and in combination with ozone
EP0158796A3 (en) Diagnostic method for detecting periodontal disease
CN201311420Y (zh) 唾液试笔
WO2003014744A3 (de) Verfahren und diagnosekit zur diagnose von helicobacter pylori
UCHIDA et al. Healing process of acetic acid-induced gastric ulcer and gastric mucosal prostaglandin E generation level in rats

Legal Events

Date Code Title Description
FG Grant or registration